MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.480
-0.050 (-3.27%)
Apr 1, 2025, 4:00 PM EST - Market closed

MAIA Biotechnology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-23.25-19.77-16.22-12.5-6.64
Upgrade
Other Amortization
---0.60.02
Upgrade
Stock-Based Compensation
1.913.092.322.723.89
Upgrade
Other Operating Activities
6.880.531.453.94-0.37
Upgrade
Change in Accounts Payable
-0.120.470.210.81-0
Upgrade
Change in Other Net Operating Assets
-1.122.610.140.321.26
Upgrade
Operating Cash Flow
-15.7-13.07-12.1-4.12-1.84
Upgrade
Long-Term Debt Issued
---7.430.67
Upgrade
Short-Term Debt Repaid
----0-0
Upgrade
Total Debt Repaid
----0-0
Upgrade
Net Debt Issued (Repaid)
---7.430.67
Upgrade
Issuance of Common Stock
18.9711.4214.446.60.19
Upgrade
Other Financing Activities
-0.8-2.15-1.97--0.06
Upgrade
Financing Cash Flow
18.189.2712.4814.030.8
Upgrade
Foreign Exchange Rate Adjustments
-0.02-0-0--
Upgrade
Net Cash Flow
2.45-3.80.389.91-1.05
Upgrade
Levered Free Cash Flow
-9.93-7.42-7.43-1.590.78
Upgrade
Unlevered Free Cash Flow
-9.93-7.41-7.43-1.670.78
Upgrade
Change in Net Working Capital
1.24-2.11-0.36-0.47-1.25
Upgrade
Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q